Mumbai MedTech Startup Bioscan Research Raises $1 Million to Advance Brain Injury Detection

The company will use the new funding to expand into more markets and reach more customers.

Bioscan Research also plans to use the investment to obtain additional regulatory approvals, improve its existing products, and develop new intellectual property (IP).

Commenting on the fund raise, Co-founders, Bioscan Research says, “We harness light to reveal what the eyes can’t see — giving doctors clarity, patients hope, and technology a heart. More than 50 million suffer from traumatic brain injury each year and 50-90% of patients with mild traumatic brain injury go unidentified. With this current round, we will be able to upgrade our product and bridge the limitations of traditional tools and provide urgent care in India and internationally.”

Anil Joshi, Managing Partner, Unicorn India Ventures says, “We have been investing in highly innovative medtech companies quite consistently as we believe the healthcare industry still has a big gap to address in countries like India. We believe the market is huge and the research is evident on how people are suffering from head injuries and brain trauma every year. It is time to bring the correct technology that will diagnose early symptoms and understand what the patient is suffering from. Bioscan Research is making it possible to detect intra-cranial haemorrhage non-invasively. The company has witnessed progress in the last 12 months and has upgraded its technology solutions. Hence, we believe the market opportunity is huge and the company has built the right momentum to capitalise on this segment.”

About Bioscan Research

Founded in 2017 by Anupam Lavania and Shilpa Malik, Bioscan Research is an ISO 13485:2016-certified medical device company that develops non-invasive diagnostic solutions to detect diseases at an early stage.

The company combines photonics, precision engineering, and machine learning (AI) to help doctors detect serious health conditions more quickly and accurately, leading to better patient care.

Its main product, Cerebo, is a device that helps detect intracranial (brain) injuries in trauma patients, even when there are no visible symptoms. This allows doctors to provide treatment quickly during the critical "golden period", improving the chances of recovery.

Read Also- B9 Beverages Begins New Chapter as Founder Ankur Jain Steps Down